# Sonic Incytes

- Location (FDA's records): Vancouver, CA
- FDA decisions: 4 (2020–2024): 4 510(k) clearances
- Product codes: IYO (4)
- 510(k) review time since 2016: median 113 days, against 177 for FDA's reviews in the same codes and years (2 of 4 faster)
- Predicates its devices cite: 4 (3 its own); citations of its devices by later devices: 4 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Echosens: 1 (https://510kreport.com/company/echosens)

## Firms that cite its devices most
- Sonic Incytes Medical Corp: 1 (https://510kreport.com/company/sonic-incytes-medical)

## Its most-cited devices
- K232459: Velacur (2023), cited by 1
- K233977: Velacur (2024), cited by 1
- K201597: Liver Incytes, Model 1005 (2020), cited by 1
- K223287: Velacur (2023), cited by 1

## Recent decisions
- K233977: Velacur (Sep 4, 2024)
- K232459: Velacur (Sep 12, 2023)
- K223287: Velacur (Apr 20, 2023)
- K201597: Liver Incytes, Model 1005 (Jul 31, 2020)

Source page: https://510kreport.com/company/sonic-incytes